BAKER BROS ADVISORS LLC Insider Trading $BGNE BeiGene, Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).

BAKER BROS ADVISORS LLC in BeiGene, Ltd.

Trading Symbol: BGNE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 10,418 shares
Current Value: $374,215
Latest Transaction: Dec 04 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in BeiGene, Ltd.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 04 2020BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorSellS220.501,386,033305,620,27710,811,04812.2 M to 10.8 M (-11.36 %)
Dec 04 2020BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorSellS220.50125,51327,675,617979,0031.1 M to 979 K (-11.36 %)
Dec 04 2020BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorGiftG0.0013,516010,41823.9 K to 10.4 K (-56.47 %)
Dec 04 2020BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorGiftG0.0013,516010,41823.9 K to 10.4 K (-56.47 %)
Jul 17 2020BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorGrantA14.2313,589,904193,395,20618,840,3795.3 M to 18.8 M (+258.83 %)
Jul 17 2020BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorGrantA14.23994,27614,149,3431,021,85127.6 K to 1 M (+3,605.72 %)
Jun 19 2020BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseA13.4290,7661,218,08090,766
Jun 07 2019BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseA9.23129,2201,192,701129,220
Jun 07 2019BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyJ0.0043,109043,1090 to 43.1 K
Jun 07 2019BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyJ0.0043,109043,1090 to 43.1 K
Jun 07 2019BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorSellJ0.00582,200018,591600.8 K to 18.6 K (-96.91 %)
Jun 07 2019BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyJ0.0013,516020,6187.1 K to 20.6 K (+190.31 %)
Jun 07 2019BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyJ0.0013,516020,6187.1 K to 20.6 K (+190.31 %)
Jun 07 2019BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorSellJ0.00182,53901,028,0341.2 M to 1 M (-15.08 %)
Aug 06 2018BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP108.005,231,900565,045,2005,250,49118.6 K to 5.3 M (+28,142.11 %)
Aug 06 2018BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP108.00582,20062,877,600600,79118.6 K to 600.8 K (+3,131.62 %)
Jun 08 2018BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseA16.1534,884563,37734,884
Jun 08 2018BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorGrantA0.0018,580073,180,60273.2 M to 73.2 M (+0.03 %)
Jun 08 2018BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorGrantA0.0018,58006,551,7156.5 M to 6.6 M (+0.28 %)
Jan 22 2018BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP101.001,645,148166,159,9485,121,4043.5 M to 5.1 M (+47.33 %)
Jan 22 2018BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP101.00335,05033,840,050708,025373 K to 708 K (+89.83 %)
Oct 16 2017BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyJ0.007,10207,1020 to 7.1 K
Oct 16 2017BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyJ0.007,10207,1020 to 7.1 K
Oct 16 2017BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorSellJ0.0049,2000049.2 K to 0 (-100.00 %)
Aug 14 2017BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP71.00158,27911,237,8093,476,2563.3 M to 3.5 M (+4.77 %)
Aug 14 2017BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP71.0017,7771,262,167372,975355.2 K to 373 K (+5.00 %)
Apr 21 2017BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseA2.84399,9841,135,955399,984
Nov 21 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP32.001,594,67151,029,4723,317,9771.7 M to 3.3 M (+92.54 %)
Nov 21 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP32.00165,8245,306,368355,198189.4 K to 355.2 K (+87.56 %)
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseX0.6856,85338,3760
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseX0.682,296,8901,550,4010
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseX0.68238,850161,2240
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseC0.0026,292,96100
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseC0.001,912,16700
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseC0.00582,74700
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseC0.0044,572,17100
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorOption ExerciseC0.004,382,11800
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP24.001,723,30641,359,3441,723,3060 to 1.7 M
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyP24.00189,3744,544,976189,3740 to 189.4 K
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyX0.6856,85338,376639,600582.7 K to 639.6 K (+9.76 %)
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyX0.682,296,8901,550,40173,162,02270.9 M to 73.2 M (+3.24 %)
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyX0.68238,850161,2246,533,1356.3 M to 6.5 M (+3.79 %)
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyC0.0026,292,961070,865,13244.6 M to 70.9 M (+58.99 %)
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyC0.001,912,16706,294,2854.4 M to 6.3 M (+43.64 %)
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyC0.00582,7470582,7470 to 582.7 K
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyC0.0044,572,171044,572,1710 to 44.6 M
Feb 09 2016BGNEBeiGene, Ltd.BAKER BROS. ADVISORS LPDirectorBuyC0.004,382,11804,382,1180 to 4.4 M

Page:   1